These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20428828)

  • 21. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.
    Moghbeli M; Moaven O; Memar B; Raziei HR; Aarabi A; Dadkhah E; Forghanifard MM; Manzari F; Abbaszadegan MR
    J Gastrointest Cancer; 2014 Mar; 45(1):40-7. PubMed ID: 24022108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; zur Hausen A; Gabbert HE; Sarbia M
    Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
    Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of EZH2 and DNA methylation in hMLH1 silencing in epithelial ovarian cancer.
    Wang J; Yu L; Cai J; Jia J; Gao Y; Liang M; Wang Z
    Biochem Biophys Res Commun; 2013 Apr; 433(4):470-6. PubMed ID: 23523787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
    Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
    Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
    Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
    Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
    Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT
    Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related hypermethylation of the hMLH1 promoter in gastric cancers.
    Nakajima T; Akiyama Y; Shiraishi J; Arai T; Yanagisawa Y; Ara M; Fukuda Y; Sawabe M; Saitoh K; Kamiyama R; Hirokawa K; Yuasa Y
    Int J Cancer; 2001 Oct; 94(2):208-11. PubMed ID: 11668499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylation in premalignant stages of gastric carcinoma.
    Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
    Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
    Fujii S; Ito K; Ito Y; Ochiai A
    J Biol Chem; 2008 Jun; 283(25):17324-32. PubMed ID: 18430739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
    Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype.
    Alves MK; Ferrasi AC; Lima VP; Ferreira MV; de Moura Campos Pardini MI; Rabenhorst SH
    Pathobiology; 2011; 78(5):266-76. PubMed ID: 21849808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability.
    Kondo E; Furukawa T; Yoshinaga K; Kijima H; Semba S; Yatsuoka T; Yokoyama T; Fukushige S; Horii A
    Int J Oncol; 2000 Sep; 17(3):535-41. PubMed ID: 10938395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
    Kang YH; Bae SI; Kim WH
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
    Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
    World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.
    Fleisher AS; Esteller M; Tamura G; Rashid A; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Nishizuka S; James SP; Wilson KT; Herman JG; Meltzer SJ
    Oncogene; 2001 Jan; 20(3):329-35. PubMed ID: 11313962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypermethylation of hMLH1, HPP1, p14(ARF), p16(INK4A) and APC in primary adenocarcinomas of the small bowel.
    Brücher BL; Geddert H; Langner C; Höfler H; Fink U; Siewert JR; Sarbia M
    Int J Cancer; 2006 Sep; 119(6):1298-302. PubMed ID: 16619216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2.
    McGarvey KM; Greene E; Fahrner JA; Jenuwein T; Baylin SB
    Cancer Res; 2007 Jun; 67(11):5097-102. PubMed ID: 17545586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.